Literature DB >> 25068017

Non-invasive evaluation of arrhythmic risk in dilated cardiomyopathy: From imaging to electrocardiographic measures.

Massimo Iacoviello1, Francesco Monitillo1.   

Abstract

Malignant ventricular arrhythmias are a major adverse event and worsen the prognosis of patients affected by ischemic and non-ischemic dilated cardiomyopathy. The main parameter currently used to stratify arrhythmic risk and guide decision making towards the implantation of a cardioverter defibrillator is the evaluation of the left ventricular ejection fraction. However, this strategy is characterized by several limitations and consequently additional parameters have been suggested in order to improve arrhythmic risk stratification. The aim of this review is to critically revise the prognostic significance of non-invasive diagnostic tools in order to better stratify the arrhythmic risk prognosis of dilated cardiomyopathy patients.

Entities:  

Keywords:  Dilated cardiomyopathy; Left ventricular systolic function; Major ventricular arrhythmias; Prognosis; Ventricular repolarization

Year:  2014        PMID： 25068017      PMCID： PMC4110605          DOI： 10.4330/wjc.v6.i7.562

Source DB:  PubMed          Journal:  World J Cardiol


  114 in total

1.  Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators?

Authors:  K Kraaier; T McCracken; J van der Palen; A A M Wilde; M F Scholten
Journal:  Neth Heart J       Date:  2011-01       Impact factor: 2.380

2.  Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value.

Authors:  L Fauchier; D Babuty; P Cosnay; M L Autret; J P Fauchier
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

3.  Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy.

Authors:  B M Szabó; D J van Veldhuisen; N van der Veer; J Brouwer; P A De Graeff; H J Crijns
Journal:  Am J Cardiol       Date:  1997-04-01       Impact factor: 2.778

4.  Prognostic Significance of Quantitative QRS Duration.

Authors:  Aseem D Desai; Tan Swee Yaw; Takuya Yamazaki; Amir Kaykha; Sung Chun; Victor F Froelicher
Journal:  Am J Med       Date:  2006-07       Impact factor: 4.965

5.  Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.

Authors:  Leah Iles; Heinz Pfluger; Lisa Lefkovits; Michelle J Butler; Peter M Kistler; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2011-02-15       Impact factor: 24.094

6.  Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.

Authors:  Jorge A Salerno-Uriarte; Gaetano M De Ferrari; Catherine Klersy; Roberto F E Pedretti; Massimo Tritto; Luciano Sallusti; Luigi Libero; Giacinto Pettinati; Giulio Molon; Antonio Curnis; Eraldo Occhetta; Fabrizio Morandi; Paolo Ferrero; Francesco Accardi
Journal:  J Am Coll Cardiol       Date:  2007-10-22       Impact factor: 24.094

7.  Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.

Authors:  Iwona Cygankiewicz; Wojciech Zareba; Rafael Vazquez; Antoni Bayes-Genis; Domingo Pascual; Carlos Macaya; Jesus Almendral; Miquel Fiol; Alfredo Bardaji; Jose R Gonzalez-Juanatey; Vicente Nieto; Mariano Valdes; Juan Cinca; Antoni Bayes de Luna
Journal:  Am J Cardiol       Date:  2009-04-01       Impact factor: 2.778

8.  Mismatch between myocardial accumulation of 123I-MIBG and 99mTc-MIBI and late ventricular potentials in patients after myocardial infarction: association with the development of ventricular arrhythmias.

Authors:  M Yukinaka; M Nomura; S Ito; Y Nakaya
Journal:  Am Heart J       Date:  1998-11       Impact factor: 4.749

Review 9.  Role of calcium in arrhythmogenesis.

Authors:  M N Levy
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

10.  The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.

Authors:  Otto Costantini; Stefan H Hohnloser; Malcolm M Kirk; Bruce B Lerman; James H Baker; Barathi Sethuraman; Mary M Dettmer; David S Rosenbaum
Journal:  J Am Coll Cardiol       Date:  2009-02-10       Impact factor: 24.094
View more
  5 in total

1.  D117N in Cypher/ZASP may not be a causative mutation for dilated cardiomyopathy and ventricular arrhythmias.

Authors:  Aviva Levitas; Yuval Konstantino; Emad Muhammad; Zaid Afawi; Jean Marc Weinstein; Guy Amit; Yoram Etzion; Ruti Parvari
Journal:  Eur J Hum Genet       Date:  2015-09-30       Impact factor: 4.246

Review 2.  Ventricular repolarization measures for arrhythmic risk stratification.

Authors:  Francesco Monitillo; Marta Leone; Caterina Rizzo; Andrea Passantino; Massimo Iacoviello
Journal:  World J Cardiol       Date:  2016-01-26

Review 3.  Risk stratification for sudden cardiac death in patients with heart failure : Emerging role of imaging parameters.

Authors:  Ikram Kammoun; Emna Bennour; Lobna Laroussi; Manel Miled; Ahmed Sghaier; Karmous Rahma; Boussema Amine; Sonia Marrakchi; Salem Kachboura
Journal:  Herz       Date:  2021-04-28       Impact factor: 1.443

Review 4.  Wearable cardioverter defibrillator: Bridge or alternative to implantation?

Authors:  Jeremie Barraud; Jennifer Cautela; Morgane Orabona; Johan Pinto; Olivier Missenard; Marc Laine; Franck Thuny; Franck Paganelli; Laurent Bonello; Michael Peyrol
Journal:  World J Cardiol       Date:  2017-06-26

5.  [Severe ventricular arrhythmias in a patient with dilated cardiomyopathy and automated implantable defibrillator (AID)].

Authors:  Stéphane Méo Ikama; Jospin Makani; Bertrand Ellenga-Mbolla; Louis Igor Ondze-Kafata; Thierry Raoul Gombet; Gisèle Kimbally-Kaky
Journal:  Pan Afr Med J       Date:  2017-05-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.